Ross MaClean
Conseiller Juridique Général chez DrugAbuse Pharmaceutical, Inc.
Profil
Ross Maclean is Chief Executive Officer of DrugAbuse Sciences SAS.
He has been Vice President of Regulatory Affairs for DrugAbuse Pharmaceutical, Inc. since December, 2003.
Dr. Maclean received a PhD from the University of Southampton.
Postes actifs de Ross MaClean
Sociétés | Poste | Début |
---|---|---|
DrugAbuse Pharmaceutical, Inc.
DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Conseiller Juridique Général | - |
Anciens postes connus de Ross MaClean
Sociétés | Poste | Fin |
---|---|---|
DrugAbuse Sciences SAS
DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | President | 23/09/2008 |
Formation de Ross MaClean
The University of Southampton | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
DrugAbuse Pharmaceutical, Inc.
DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Health Technology |
DrugAbuse Sciences SAS
DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | Health Technology |